Showing results (1701-1710 of 31,365) with videos related to
Sort By:
Pageof 3,137
Journal of Medicinal Chemistry|June 13, 2019
De Novo Design of Boron-Based Peptidomimetics as Potent Inhibitors of Human ClpP in the Presence of Human ClpXJoanne Tan, Julie J Grouleff, Yulia Jitkova, et al.Journal of Medicinal Chemistry|March 1, 1988
Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinasesJ Maibaum, D H RichJournal of Medicinal Chemistry|July 4, 2019
Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease ResearchDean G Brown, Heike J WobstJournal of Medicinal Chemistry|July 11, 2019
Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System DiseasesMarzena Mazur, Barbara Dymek, Robert Koralewski, et al.Journal of Medicinal Chemistry|July 10, 2019
Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid ArthritisEmanuela Berrino, Lisa Milazzo, Laura Micheli, et al.Journal of Medicinal Chemistry|October 12, 2019
Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric InhibitorsXi Xu, Zijian Kuang, Jie Han, et al.Journal of Medicinal Chemistry|October 12, 2019
The Blood-Brain Barrier (BBB) ScoreMayuri Gupta, Hyeok Jun Lee, Christopher J Barden, et al.Journal of Medicinal Chemistry|October 12, 2019
Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune StimuliMichael Chan, Fitzgerald S Lao, Paul J Chu, et al.Journal of Medicinal Chemistry|July 2, 2019
Computationally Driven Structure Optimization, Synthesis, and Biological Evaluation of Imidazole-Based Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) InhibitorsCarmen Lammi, Jacopo Sgrignani, Anna Arnoldi, et al.Journal of Medicinal Chemistry|July 6, 2019
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)Xiaohui Du, John Eksterowicz, Haiying Zhou, et al.Pageof 3,137